179 related articles for article (PubMed ID: 2989419)
61. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
Aurelian L; Smith CC; Wachsman M; Paoletti E
Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
[TBL] [Abstract][Full Text] [Related]
62. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie S; Maingay J; Neill WA
Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
[TBL] [Abstract][Full Text] [Related]
63. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
Skinner GR; Woodman CB; Hartley CE; Buchan A; Fuller A; Durham J; Synnott M; Clay JC; Melling J; Wiblin C; Wilkins J
Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
[TBL] [Abstract][Full Text] [Related]
64. A test for the relative potency of herpes simplex virus vaccines based upon the female guinea-pig model of HSV 2 genital infection.
Phillpotts RJ; Welch MJ; Ridgeway PH; Walkland AC; Melling J
J Biol Stand; 1988 Apr; 16(2):109-18. PubMed ID: 2836425
[TBL] [Abstract][Full Text] [Related]
65. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
[TBL] [Abstract][Full Text] [Related]
66. Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines.
Bernstein DI; Ashley RL; Stanberry LR; Myers MG
J Clin Microbiol; 1990 Jan; 28(1):11-5. PubMed ID: 2153698
[TBL] [Abstract][Full Text] [Related]
67. Vaccines against genital herpes: progress and limitations.
Morrison LA
Drugs; 2002; 62(8):1119-29. PubMed ID: 12010075
[TBL] [Abstract][Full Text] [Related]
68. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
[TBL] [Abstract][Full Text] [Related]
69. Sequential genital infections by herpes simplex viruses types 1 and 2: restriction nuclease analyses of viruses from recurrent infections.
Kit S; Trkula D; Qavi H; Dreesman G; Kennedy RC; Adler-Storthz K; Kaufman R; Adam E
Sex Transm Dis; 1983; 10(2):67-71. PubMed ID: 6318371
[TBL] [Abstract][Full Text] [Related]
70. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.
Da Costa XJ; Jones CA; Knipe DM
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6994-8. PubMed ID: 10359827
[TBL] [Abstract][Full Text] [Related]
71. Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunized with HSV subunit vaccines.
Bernstein DI; Stanberry LR; Kappes JC; Burke RL; Myers MG
J Infect Dis; 1988 Jun; 157(6):1178-86. PubMed ID: 2836519
[TBL] [Abstract][Full Text] [Related]
72. The diagnosis of recent herpes simplex virus type 2 genital infections by the simplex-2 test.
Field PR; Ho DW; Cunningham AL
Pathology; 1992 Oct; 24(4):302-6. PubMed ID: 1337770
[TBL] [Abstract][Full Text] [Related]
73. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
Prober CG; Sullender WM; Yasukawa LL; Au DS; Yeager AS; Arvin AM
N Engl J Med; 1987 Jan; 316(5):240-4. PubMed ID: 3025727
[TBL] [Abstract][Full Text] [Related]
74. Generating protective immunity against genital herpes.
Shin H; Iwasaki A
Trends Immunol; 2013 Oct; 34(10):487-94. PubMed ID: 24012144
[TBL] [Abstract][Full Text] [Related]
75. Serological assessment of acyclovir treatment of herpes genitalis.
Ragab NF; Habib MA; Ghozzi MY
Arch Androl; 1989; 23(2):147-53. PubMed ID: 2556084
[TBL] [Abstract][Full Text] [Related]
76. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus.
Merriman H; Woods S; Winter C; Fahnlander A; Corey L
J Infect Dis; 1984 Apr; 149(4):505-10. PubMed ID: 6327834
[TBL] [Abstract][Full Text] [Related]
77. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
[TBL] [Abstract][Full Text] [Related]
78. Neutralizing antibody to herpes simplex in pregnant women and their neonates.
Harger JH; Guevarra L; Armstrong JA
J Perinatol; 1990 Mar; 10(1):16-9. PubMed ID: 2156030
[TBL] [Abstract][Full Text] [Related]
79. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.
; Abu-Elyazeed RR; Heineman T; Dubin G; Fourneau M; Leroux-Roels I; Leroux-Roels G; Richardus JH; Ostergaard L; Diez-Domingo J; Poder A; Van Damme P; Romanowski B; Blatter M; Silfverdal SA; Berglund J; Josefsson A; Cunningham AL; Flodmark CE; Tragiannidis A; Dobson S; Olafsson J; Puig-Barbera J; Mendez M; Barton S; Bernstein D; Mares J; Ratner P
Vaccine; 2013 Dec; 31(51):6136-43. PubMed ID: 23850416
[TBL] [Abstract][Full Text] [Related]
80. Vaccines to prevent genital herpes.
Egan K; Hook LM; LaTourette P; Desmond A; Awasthi S; Friedman HM
Transl Res; 2020 Jun; 220():138-152. PubMed ID: 32272093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
